PMC:7556165 / 77339-78289
Annnotations
LitCovid-sample-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T209 | 312-324 | Chemical | denotes | glycoprotein | http://purl.obolibrary.org/obo/CHEBI_17089 |
| T210 | 408-415 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-sample-PD-NCBITaxon
| Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
|---|---|---|---|---|---|
| T412 | 11-19 | Species | denotes | COVID-19 | NCBItxid:2697049 |
| T413 | 118-122 | Species | denotes | SARS | NCBItxid:694009 |
| T414 | 131-140 | Species | denotes | SARS-Cov2 | NCBItxid:2697049 |
| T415 | 131-135 | Species | denotes | SARS | NCBItxid:694009 |
| T416 | 141-148 | Species | denotes | viruses | NCBItxid:10239 |
| T417 | 568-576 | Species | denotes | COVID-19 | NCBItxid:2697049 |
| T418 | 813-821 | Species | denotes | COVID-19 | NCBItxid:2697049 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T460 | 0-210 | Sentence | denotes | The recent COVID-19 pandemic has put ACE2 in the spotlight, since it has been identified as the initial target of the SARS-Cov and SARS-Cov2 viruses, representing the receptor responsible for cellular adhesion. |
| T461 | 211-444 | Sentence | denotes | Recent investigations have clarified the molecular details of the interaction of ACE2 with the spike glycoprotein present in this class of coronaviruses, and have partly unraveled the mechanism of protein cleavage and cellular entry. |
| T462 | 445-743 | Sentence | denotes | ACE2 density on cell surface and ACE2-modulated inflammatory reactions have been suggested to be important determinants of COVID-19 susceptibility and clinical course, while drugs interfering with ACE2 expression, availability and processing are under investigation as potential therapeutic agents. |
| T463 | 744-950 | Sentence | denotes | However, several crucial issues concerning the link between ACE2 and COVID-19 pathophysiology are still unclear, pointing to the need for focused experimental investigations and prospective clinical trials. |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 2154 | 37-41 | Gene | denotes | ACE2 | Gene:59272 |
| 2155 | 292-296 | Gene | denotes | ACE2 | Gene:59272 |
| 2156 | 445-449 | Gene | denotes | ACE2 | Gene:59272 |
| 2157 | 478-482 | Gene | denotes | ACE2 | Gene:59272 |
| 2158 | 642-646 | Gene | denotes | ACE2 | Gene:59272 |
| 2159 | 804-808 | Gene | denotes | ACE2 | Gene:59272 |
| 2160 | 118-126 | Species | denotes | SARS-Cov | Tax:694009 |
| 2161 | 131-140 | Species | denotes | SARS-Cov2 | Tax:2697049 |
| 2162 | 350-363 | Species | denotes | coronaviruses | Tax:11118 |
| 2163 | 11-19 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 2164 | 568-576 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 2165 | 813-821 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sample-UniProt
| Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
|---|---|---|---|---|---|
| T6643 | 37-41 | Protein | denotes | ACE2 | https://www.uniprot.org/uniprot/Q9UFZ6 |
| T6644 | 292-296 | Protein | denotes | ACE2 | https://www.uniprot.org/uniprot/Q9UFZ6 |
| T6645 | 306-324 | Protein | denotes | spike glycoprotein | https://www.uniprot.org/uniprot/Q9QAS2|https://www.uniprot.org/uniprot/Q9QAR5|https://www.uniprot.org/uniprot/Q9QAQ8|https://www.uniprot.org/uniprot/Q9IW04|https://www.uniprot.org/uniprot/Q9IKD1|https://www.uniprot.org/uniprot/Q990M4|https://www.uniprot.org/uniprot/Q990M3|https://www.uniprot.org/uniprot/Q990M2|https://www.uniprot.org/uniprot/Q990M1|https://www.uniprot.org/uniprot/Q91AV1|https://www.uniprot.org/uniprot/Q91A26|https://www.uniprot.org/uniprot/Q8V436|https://www.uniprot.org/uniprot/Q8JSP8|https://www.uniprot.org/uniprot/Q8BB25|https://www.uniprot.org/uniprot/Q86623|https://www.uniprot.org/uniprot/Q85088|https://www.uniprot.org/uniprot/Q85087|https://www.uniprot.org/uniprot/Q82706|https://www.uniprot.org/uniprot/Q82683|https://www.uniprot.org/uniprot/Q80BV6|https://www.uniprot.org/uniprot/Q7TFB1|https://www.uniprot.org/uniprot/Q7TFA2|https://www.uniprot.org/uniprot/Q7TA19|https://www.uniprot.org/uniprot/Q7T6T3|https://www.uniprot.org/uniprot/Q7T696|https://www.uniprot.org/uniprot/Q77NC4|https://www.uniprot.org/uniprot/Q6TNF9|https://www.uniprot.org/uniprot/Q6R1L7|https://www.uniprot.org/uniprot/Q6QU82|https://www.uniprot.org/uniprot/Q6Q1S2|https://www.uniprot.org/uniprot/Q696Q6|https://www.uniprot.org/uniprot/Q66291|https://www.uniprot.org/uniprot/Q66290|https://www.uniprot.org/uniprot/Q66199|https://www.uniprot.org/uniprot/Q66177|https://www.uniprot.org/uniprot/Q66176|https://www.uniprot.org/uniprot/Q66174|https://www.uniprot.org/uniprot/Q65984|https://www.uniprot.org/uniprot/Q5MQD0|https://www.uniprot.org/uniprot/Q5I5X9|https://www.uniprot.org/uniprot/Q5DIY0|https://www.uniprot.org/uniprot/Q5DIX9|https://www.uniprot.org/uniprot/Q5DIX8|https://www.uniprot.org/uniprot/Q5DIX7|https://www.uniprot.org/uniprot/Q52PA3|https://www.uniprot.org/uniprot/Q4ZJS1|https://www.uniprot.org/uniprot/Q4U5G0|https://www.uniprot.org/uniprot/Q3T8J0|https://www.uniprot.org/uniprot/Q3LZX1|https://www.uniprot.org/uniprot/Q3I5J5|https://www.uniprot.org/uniprot/Q14EB0|https://www.uniprot.org/uniprot/Q0ZME7|https://www.uniprot.org/uniprot/Q0Q4F2|https://www.uniprot.org/uniprot/Q0Q475|https://www.uniprot.org/uniprot/Q0Q466|https://www.uniprot.org/uniprot/Q0GNB8|https://www.uniprot.org/uniprot/Q02385|https://www.uniprot.org/uniprot/Q02167|https://www.uniprot.org/uniprot/Q01977|https://www.uniprot.org/uniprot/Q008X4|https://www.uniprot.org/uniprot/P89344|https://www.uniprot.org/uniprot/P89343|https://www.uniprot.org/uniprot/P89342|https://www.uniprot.org/uniprot/P59594|https://www.uniprot.org/uniprot/P36334|https://www.uniprot.org/uniprot/P36300|https://www.uniprot.org/uniprot/P33470|https://www.uniprot.org/uniprot/P30208|https://www.uniprot.org/uniprot/P30207|https://www.uniprot.org/uniprot/P30206|https://www.uniprot.org/uniprot/P27662|https://www.uniprot.org/uniprot/P27655|https://www.uniprot.org/uniprot/P27277|https://www.uniprot.org/uniprot/P25194|https://www.uniprot.org/uniprot/P25193|https://www.uniprot.org/uniprot/P25192|https://www.uniprot.org/uniprot/P25191|https://www.uniprot.org/uniprot/P25190|https://www.uniprot.org/uniprot/P24413|https://www.uniprot.org/uniprot/P23052|https://www.uniprot.org/uniprot/P22432|https://www.uniprot.org/uniprot/P18450|https://www.uniprot.org/uniprot/P17662|https://www.uniprot.org/uniprot/P15777|https://www.uniprot.org/uniprot/P15423|https://www.uniprot.org/uniprot/P12722|https://www.uniprot.org/uniprot/P12651|https://www.uniprot.org/uniprot/P12650|https://www.uniprot.org/uniprot/P12647|https://www.uniprot.org/uniprot/P11225|https://www.uniprot.org/uniprot/P11224|https://www.uniprot.org/uniprot/P11223|https://www.uniprot.org/uniprot/P10033|https://www.uniprot.org/uniprot/P0DTC2|https://www.uniprot.org/uniprot/P07946|https://www.uniprot.org/uniprot/P07923|https://www.uniprot.org/uniprot/P05135|https://www.uniprot.org/uniprot/P05134|https://www.uniprot.org/uniprot/O90304|https://www.uniprot.org/uniprot/O39227|https://www.uniprot.org/uniprot/K9N5Q8|https://www.uniprot.org/uniprot/A3EXG6|https://www.uniprot.org/uniprot/A3EXD0|https://www.uniprot.org/uniprot/A3EX94 |
| T6749 | 445-449 | Protein | denotes | ACE2 | https://www.uniprot.org/uniprot/Q9UFZ6 |
| T6750 | 478-482 | Protein | denotes | ACE2 | https://www.uniprot.org/uniprot/Q9UFZ6 |
| T6751 | 642-646 | Protein | denotes | ACE2 | https://www.uniprot.org/uniprot/Q9UFZ6 |
| T6752 | 804-808 | Protein | denotes | ACE2 | https://www.uniprot.org/uniprot/Q9UFZ6 |
LitCovid-sample-PD-IDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T316 | 141-148 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
| T317 | 461-465 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cell |
| T318 | 577-591 | http://purl.obolibrary.org/obo/IDO_0000467 | denotes | susceptibility |
LitCovid-sample-PD-FMA
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T505 | 312-324 | Body_part | denotes | glycoprotein | http://purl.org/sig/ont/fma/fma62925 |
| T506 | 408-415 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T507 | 461-473 | Body_part | denotes | cell surface | http://purl.org/sig/ont/fma/fma67653 |
| T508 | 461-465 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-sample-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T473 | 11-19 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T474 | 118-122 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T475 | 131-140 | Disease | denotes | SARS-Cov2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T476 | 131-135 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T477 | 568-576 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T478 | 813-821 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2154 | 37-41 | Gene | denotes | ACE2 | Gene:59272 |
| 2155 | 292-296 | Gene | denotes | ACE2 | Gene:59272 |
| 2156 | 445-449 | Gene | denotes | ACE2 | Gene:59272 |
| 2157 | 478-482 | Gene | denotes | ACE2 | Gene:59272 |
| 2158 | 642-646 | Gene | denotes | ACE2 | Gene:59272 |
| 2159 | 804-808 | Gene | denotes | ACE2 | Gene:59272 |
| 2160 | 118-126 | Species | denotes | SARS-Cov | Tax:694009 |
| 2161 | 131-140 | Species | denotes | SARS-Cov2 | Tax:2697049 |
| 2162 | 350-363 | Species | denotes | coronaviruses | Tax:11118 |
| 2163 | 11-19 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 2164 | 568-576 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 2165 | 813-821 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T460 | 0-210 | Sentence | denotes | The recent COVID-19 pandemic has put ACE2 in the spotlight, since it has been identified as the initial target of the SARS-Cov and SARS-Cov2 viruses, representing the receptor responsible for cellular adhesion. |
| T461 | 211-444 | Sentence | denotes | Recent investigations have clarified the molecular details of the interaction of ACE2 with the spike glycoprotein present in this class of coronaviruses, and have partly unraveled the mechanism of protein cleavage and cellular entry. |
| T462 | 445-743 | Sentence | denotes | ACE2 density on cell surface and ACE2-modulated inflammatory reactions have been suggested to be important determinants of COVID-19 susceptibility and clinical course, while drugs interfering with ACE2 expression, availability and processing are under investigation as potential therapeutic agents. |
| T463 | 744-950 | Sentence | denotes | However, several crucial issues concerning the link between ACE2 and COVID-19 pathophysiology are still unclear, pointing to the need for focused experimental investigations and prospective clinical trials. |